-+ 0.00%
-+ 0.00%
-+ 0.00%

Innate Pharma reports 93,860,680 shares outstanding, 94,465,868 exercisable voting rights

PUBT·04/13/2026 05:00:24
Listen to the news
Innate Pharma reports 93,860,680 shares outstanding, 94,465,868 exercisable voting rights
  • Innate Pharma reported 93,860,680 shares outstanding as of April 9, 2026.
  • The company disclosed 94,484,443 theoretical voting rights on the same date.
  • Exercisable voting rights totaled 94,465,868.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innate Pharma SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202604130100BIZWIRE_USPR_____20260412_BW718494) on April 13, 2026, and is solely responsible for the information contained therein.